Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of Cas-Br-M murine leukemia virus-infected mice

Virology

Volumn 268, Issue 2, 2000, Pages 308-318

  Joosten, Marieke ^a   Valk, Peter J M ^a   Vankan, Yolanda ^a   De Both, Nico ^a   Löwenberg, Bob ^a   Delwel, Ruud ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cas Br M murine leukemia virus; Common virus integration site; Retrovirally induced leukemia

Indexed keywords

ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INSERTION; GENE MUTATION; GENE REARRANGEMENT; IMMUNOPHENOTYPING; MALE; MOUSE; MURINE LEUKEMIA VIRUS; MYELOID LEUKEMIA; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS DNA CELL DNA INTERACTION; VIRUS ISOLATION; VIRUS TRANSFORMATION;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034653540     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0183     Document Type: Article

References (65)

1. Adams J. M., Cory S. Oncogene co-operation in leukaemogenesis. Cancer Surv. 15:1992;119-141.
2. Aihara Y., Buhring H. J., Aihara M., Klein J. An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur. J. Immunol. 16:1986;1391-1399.
3. Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:1981;805-815.
4. Bartholomew C., Morishita K., Askew D., Buchberg A., Jenkins N. A., Copeland N. G., Ihle J. N. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene. 4:1989;529-534.
5. Baumbach W. R., Colston E. M., Cole M. D. Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor. J. Virol. 62:1988;3151-3155.
6. Ben-David Y., Giddens E. B., Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA. 87:1990;1332-1336.
7. Ben-David Y., Giddens E. B., Letwin K., Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:1991;908-918.
8. Bergeron D., Houde J., Poliquin L., Barbeau B., Rassart E. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias. Leukemia. 7:1993;954-962.
9. Bergeron D., Poliquin L., Houde J., Barbeau B., Rassart E. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br- E MuLV-induced non-T-, non-B-cell leukemias. Virology. 191:1992;661-669.
10. Bergeron D., Poliquin L., Kozak C. A., Rassart E. Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas. J. Virol. 65:1991;7-15.
11. Buchberg A. M., Bedigian H. G., Jenkins N. A., Copeland N. G. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol. Cell. Biol. 10:1990;4658-4666.
12. Coffman R. L. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:1982;5-23.
13. de Boer C. J., van Krieken J. H., Schuuring E., Kluin P. M. Bcl-1/cyclin D1 in malignant lymphoma. Ann. Oncol. 8:1997;109-117.
14. Di Majo V., Coppola M., Rebessi S., Saran A., Pazzaglia S., Pariset L., Covelli V. The influence of sex on life shortening and tumor induction in CBA/Cne mice exposed to X rays or fission neutrons. Radiat. Res. 146:1996;81-87.
15. Dreyfus F., Bouscary D., Melle J., Ribrag V., Guesnu M., Varet B. Expression of the Evi-1 gene in myelodysplastic syndromes. Leukemia. 9:1995;203-205.
16. Duby A. D., Klein K. A., Murre C., Seidman J. G. A novel mechanism of somatic rearrangement predicted by a human T-cell antigen receptor beta-chain complementary DNA. Science. 228:1985;1204-1206.
17. Duhrsen U., Stahl J., Gough N. M. In vivo transformation of factor-dependent hemopoietic cells: Role of intracisternal A-particle transposition for growth factor gene activation. EMBO J. 9:1990;1087-1096.
18. Hartley J. W., Rowe W. P. Naturally occurring murine leukemia viruses in wild mice: Characterization of a new "amphotropic" class. J. Virol. 19:1976;19-25.
19. Hestdal K., Ruscetti F. W., Ihle J. N., Jacobsen S. E., Dubois C. M., Kopp W. C., Longo D. L., Keller J. R. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:1991;22-28.
20. Hirvonen H., Hukkanen V., Salmi T. T., Pelliniemi T. T., Alitalo R. L-myc and N-myc in hematopoietic malignancies. Leuk. Lymphoma. 11:1993;197-205.
21. Holmes K. L., Langdon W. Y., Fredrickson T. N., Coffman R. L., Hoffman P. M., Hartley J. W., Morse H. C. d. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. J. Immunol. 137:1986;679-688.
22. Holmes K. L., Palaszynski E., Fredrickson T. N., Morse H. C. D., Ihle J. N. Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc. Natl. Acad. Sci. USA. 82:1985;6687-6691.
23. Honjo T., Nakai S., Nishida Y., Kataoka T., Yamawaki-Kataoka Y., Takahashi N., Obata M., Shimizu A., Yaoita Y., Nikaido T., Ishida N. Rearrangements of immunoglobulin genes during differentiation and evolution. Immunol. Rev. 59:1981;33-67.
24. Hunter T. Cooperation between oncogenes. Cell. 64:1991;249-270.
25. Ihle J. N., Morishita K., Matsugi T., Bartholomew C. Insertional mutagenesis and transformation of hematopoietic stem cells. Prog. Clin. Biol. Res. 352:1990;329-337.
26. Ikuta K., Kina T., MacNeil I., Uchida N., Peault B., Chien Y. H., Weissman I. L. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell. 62:1990;863-874.
27. Introna M., Luchetti M., Castellano M., Arsura M., Golay J. The myb oncogene family of transcription factors: Potent regulators of hematopoietic cell proliferation and differentiation. Semin. Cancer Biol. 5:1994;113-124.
28. Jolicoeur P., Nicolaiew N., DesGroseillers L., Rassart E. Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. J. Virol. 45:1983;1159-1163.
29. Jonkers J., Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta. 1287:1996;29-57.
30. Kreider B. L., Orkin S. H., Ihle J. N. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc. Natl. Acad. Sci. USA. 90:1993;6454-6458.
31. Ledbetter J. A., Herzenberg L. A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:1979;63-90.
32. Leenen P. J., Kroos M. J., Melis M., Slieker W. A., van Ewijk W., van Eijk H. G. Differential inhibition of macrophage proliferation by anti-transferrin receptor antibody ER-MP21: Correlation to macrophage differentiation stage. Exp. Cell Res. 189:1990a;55-63.
33. Leenen P. J., Melis M., Slieker W. A., Van Ewijk W. Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur. J. Immunol. 20:1990b;27-34.
34. Leslie K. B., Lee F., Schrader J. W. Intracisternal A-type particle-mediated activations of cytokine genes in a murine myelomonocytic leukemia: Generation of functional cytokine mRNAs by retroviral splicing events. Mol. Cell. Biol. 11:1991;5562-5570.
35. Moreau-Gachelin F., Tavitian A., Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 331:1988;277-280.
36. Morishita K., Parganas E., Bartholomew C., Sacchi N., Valentine M. B., Raimondi S. C., Le Beau M. M., Ihle J. N. The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations. Oncogene Res. 5:1990;221-231.
37. Morishita K., Parganas E., Matsugi T., Ihle J. N. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol. Cell. Biol. 12:1992;183-189.
38. Morishita K., Parker D. S., Mucenski M. L., Jenkins N. A., Copeland N. G., Ihle J. N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell. 54:1988;831-840.
39. Mucenski M. L., Taylor B. A., Ihle J. N., Hartley J. W., Morse H. C. d., Jenkins N. A., Copeland N. G. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol. Cell. Biol. 8:1988;301-308.
40. Nakamura T., Largaespada D. A., Lee M. P., Johnson L. A., Ohyashiki K., Toyama K., Chen S. J., Willman C. L., Chen I. M., Feinberg A. P., Jenkins N. A., Copeland N. G., Shaughnessy J. D. Jr. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12:1996a;154-158.
41. Nakamura T., Largaespada D. A., Shaughnessy J. D. Jr., Jenkins N. A., Copeland N. G. Cooperative activation of Hoxa- and Pbx1-related genes in murine myeloid leukaemias [see comments]. Nat. Genet. 12:1996b;149-153.
42. Nason-Burchenal K., Wolff L. Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc. Natl. Acad. Sci. USA. 90:1993;1619-1623.
43. Nazarov V., Wolff L. Novel integration sites at the distal 3′ end of the c-myb locus in retrovirus-induced promonocytic leukemias. J. Virol. 69:1995;3885-3888.
44. Ott D. E., Keller J., Sill K., Rein A. Phenotypes of murine leukemia virus-induced tumors: Influence of 3′ viral coding sequences. J. Virol. 66:1992;6107-6116.
45. Pevny L., Lin C. S., D'Agati V., Simon M. C., Orkin S. H., Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 121:1995;163-172.
46. Pevny L., Simon M. C., Robertson E., Klein W. H., Tsai S. F., D'Agati V., Orkin S. H., Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:1991;257-260.
47. Rasheed S., Pal B. K., Gardner M. B. Characterization of a highly oncogenic murine leukemia virus from wild mice. Int. J. Cancer. 29:1982;345-350.
48. Setoguchi M., Higuchi Y., Yoshida S., Nasu N., Miyazaki Y., Akizuki S., Yamamoto S. Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids. Mol. Cell. Biol. 9:1989;4515-4522.
49. Shannon K. M., O'Connell P., Martin G. A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders [see comments]. N. Engl. J. Med. 330:1994;597-601.
50. Shen-Ong G. L., Morse H. C. d., Potter M., Mushinski J. F. Two modes of c-myb activation in virus-induced mouse myeloid tumors [published erratum appears in Mol. Cell. Biol. (1986) 6:2756]. Mol. Cell. Biol. 6:1986;380-392.
51. Shen-Ong G. L., Wolff L. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: Requirement of c-myb activation but lack of v-abl involvement. J. Virol. 61:1987;3721-3725.
52. Shimizu K., Ichikawa H., Tojo A., Kaneko Y., Maseki N., Hayashi Y., Ohira M., Asano S., Ohki M. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc. Natl. Acad. Sci. USA. 90:1993;10280-10284.
53. Side L. E., Emanuel P. D., Taylor B., Franklin J., Thompson P., Castleberry R. P., Shannon K. M. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood. 92:1998;267-272.
54. Siglin J. C., Weghorst C. M., Rodwell D. E., Klaunig J. E. Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane. J. Toxicol. Environ. Health. 44:1995;235-245.
55. Silver J., Buckler C. E. A preferred region for integration of Friend murine leukemia virus in hematopoietic neoplasms is closely linked to the Int-2 oncogene. J. Virol. 60:1986;1156-1158.
56. Springer T., Galfre G., Secher D. S., Milstein C. Mac-1: A macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:1979;301-306.
57. Storch T. G., Chused T. M. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus. J. Immunol. 133:1984;2797-2800.
58. Tanigawa T., Robb L., Green A. R., Begley C. G. Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI-3BD. Cell Growth Differ. 5:1994;557-561.
59. Tomonari K. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics. 28:1988;455-458.
60. Valk P. J., Hol S., Vankan Y., Ihle J. N., Askew D., Jenkins N. A., Gilbert D. J., Copeland N. G., de Both N. J., Lowenberg B., Delwel R. The genes encoding the peripheral cannabinoid receptor and alpha-l-fucosidase are located near a newly identified common virus integration site, Evi11. J. Virol. 71:1997a;6796-6804.
61. Valk P. J., Vankan Y., Joosten M., Jenkins N. A., Copeland N. G., Lowenberg B., Delwel R. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2. J. Virol. 73:1999;3595-3602.
62. Valk P. J. M., Joosten M., Vankan Y., Lowenberg B., Delwel R. A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites. Nucleic Acids Res. 25:1997b;4419-4421.
63. Vogelstein B., Kinzler K. W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
64. Wolff L. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochim. Biophys. Acta. 1332:1997;F67-F104.
65. Yoshida K., Nemoto K., Nishimura M., Seki M. Exacerbating factors of radiation-induced myeloid leukemogenesis. Leuk. Res. 17:1993;437-440.